Yingzhong Lin

Yingzhong Lin

Auto-generated profile, based on publicly available information

Yingzhong Lin

Department of Cardiology the People's Hospital of Guangxi Zhuang Autonomous Region Nanning China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in EBioMedicine
Verified
Journal Article
Open access
JYJing Ye
Jing Ye
YHYing Huang
Ying Huang
BQBin Que
Bin Que
CCChao Chang
Chao Chang
WLWenjing Liu
Wenjing Liu
QJQingwei Ji
Qingwei Ji
Recent evidence has demonstrated that interleukin 12p35 knockout (IL-12p35 KO) is involved in cardiac diseases by regulating the inflammatory response. The involvement of inflammatory cells has also been observed in doxorubicin (DOX)-induced cardiac injury. This study aimed to investigate whether IL-12p35 KO affects DOX-induced cardiac injury and the underlying mechanisms. First, the effect of DOX treatment on cardiac IL-12p35 expression was assessed. In addition, to investigate the effect of IL-12p35 KO on DOX-induced cardiac injury, IL-12p35 KO mice were treated with DOX. Because IL-12p35 is the mutual subunit of IL-12 and IL-35, to determine the cytokine that mediates the effect of IL-12p35 KO on DOX-induced cardiac injury, mice were given phosphate-buffered saline (PBS), mouse recombinant IL-12 (rIL-12) or rIL-35 before treatment with DOX. DOX treatment significantly increased the level of cardiac IL-12p35 expression. In addition, IL-12p35 KO mice exhibited higher serum and heart lactate dehydrogenase levels, higher serum and heart creatine kinase myocardial bound levels, and greater cardiac dysfunction than DOX-treated mice. Furthermore, IL-12p35 KO further increased M1 macrophage and decreased M2 macrophage differentiation, aggravated the imbalance of oxidants and antioxidants, and further activated the mitochondrial apoptotic pathway and endoplasmic reticulum stress autophagy pathway. Both rIL-12 and rIL-35 protected against DOX-induced cardiac injury by alleviating the inflammatory response, oxidative stress, apoptosis and autophagy. IL-12p35 KO aggravated DOX-induced cardiac injury by amplifying the levels of inflammation, oxidative stress, apoptosis and autophagy. (234 words).

6 September 2018 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
JYJing Ye
Jing Ye
YWYuan Wang
Yuan Wang
ZWZhen Wang
Zhen Wang
QJQingwei Ji
Qingwei Ji
YHYing Huang
Ying Huang
YLYingzhong Lin
Yingzhong Lin
Background. Previous studies demonstrated that the subsets of CD4+ T helper (Th) cells are closely related to vascular diseases, including atherosclerosis and hypertension. This study is aimed at investigating the circulating Th1, Th2, Th9, Th17, Th22, and Treg levels in aortic dissection (AD) patients. Methods. Blood samples from AD (n=56) and non-AD (NAD, n=24) patients were collected, and the circulating levels of Th1, Th2, Th9, Th17, Th22, and Treg cells and their transcription factors and functional cytokines were measured by flow cytometric analysis, quantitative polymerase chain reaction, and enzyme-linked immunosorbent assays, respectively. In addition, the human aortic vascular smooth muscle cells (HASMCs) were treated with saline, angiotensin II (Ang II), or plasma from AD patients. Results. Compared with the levels in the NAD group, the Th1, Th9, Th17, Th22, and their transcription factor levels were increased and the Th2, Treg, and their transcription factor levels exhibited a decreasing trend in AD patients. In addition, higher IFN-γ, IL-9, IL-17, and IL-22 levels and lower IL-4 and IL-35 levels were observed in AD patients. Simple linear regression analysis and binary logistic regression analysis suggested that Th1/IFN-γ, IL-9, Th17/IL-17, and Th22/IL-22 positively regulated the occurrence of AD, while Th2/IL-4 and Treg/IL-35 negatively regulated the occurrence of AD. Plasma from AD patients further increased Bax mRNA levels but decreased Bcl2 and α-SMA mRNA levels in Ang II-treated HASMCs. Conclusions. Changes in Th1, Th2, Th9, Th17, Th22, and Treg activity are associated with the onset of AD. Different subsets of CD4+ T cells play different roles in the presence of AD.

11 October 2017 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
JYJing Ye
Jing Ye
QJQingwei Ji
Qingwei Ji
JLJianfang Liu
Jianfang Liu
LLLing Liu
Ling Liu
YHYing Huang
Ying Huang
JWJun Wan
Jun Wan
Background: CD 4+ T helper (Th) cells, including Th1, Th2, and Th17 cells, play critical roles in angiotensin II –induced hypertension. Th22 cells, a novel subset of Th cells, take part in cardiovascular diseases by producing IL ‐22 (interleukin 22). This study aimed to investigate whether IL ‐22 is involved in hypertension. Methods and Results: Th22 cells and IL ‐22 levels were detected in angiotensin II –infused mice, and the results showed that Th22 cells and IL ‐22 levels significantly increased. To determine the effect of Th22/ IL ‐22 on blood pressure regulation, angiotensin II –infused mice were treated with recombinant mouse IL ‐22, an anti– IL ‐22 neutralizing monoclonal antibody, or control. Treatment with recombinant IL ‐22 resulted in increased blood pressure, amplified inflammatory responses, and aggravated endothelial dysfunction, whereas the anti– IL ‐22 neutralizing monoclonal antibody decreased blood pressure, reduced inflammatory responses, and attenuated endothelial dysfunction. To determine whether the STAT 3 (signal transducer and activator of transcription 3) pathway mediates the effect of IL ‐22 on blood pressure regulation, the special STAT 3 pathway inhibitor S31‐201 was administered to mice treated with recombinant IL ‐22. S31‐201 treatment significantly ameliorated the IL ‐22 effects of increased blood pressure and endothelial dysfunction. In addition, serum IL ‐22 levels were significantly increased in hypertensive patients compared with healthy persons. Correlation analysis showed a positive correlation between IL ‐22 levels and blood pressure. Conclusions: IL ‐22 amplifies the inflammatory response, induces endothelial dysfunction and promotes blood pressure elevation in angiotensin II –induced hypertensive mice. The STAT 3 pathway mediates the effect of IL ‐22 on hypertension. Blocking IL ‐22 may be a novel therapeutic strategy to prevent and treat hypertension.

1 January 2017 in Disease Markers
Verified
Journal Article
Open access
PDF file
QJQingwei Ji
Qingwei Ji
GCGuojie Cheng
Guojie Cheng
NMNing Ma
Ning Ma
YHYing Huang
Ying Huang
YLYingzhong Lin
Yingzhong Lin
SNShaoping Nie
Shaoping Nie
Background. Evidence from experimental studies showed that Th1, Th2, and Th17 play a pivotal role in hypertension and target organ damage. However, whether changes in the circulating Th1, Th2, and Th17 levels are associated with nondipper hypertension and carotid atherosclerotic plaque in hypertension has yet to be investigated. Methods. Th1, Th2, and Th17 levels were detected using a flow cytometric analysis, and their related cytokines were measured by enzyme-linked immunosorbent assay in 45 hypertensive patients and 15 normotensive subjects. Results. The frequencies of Th1 and Th17 in hypertensive patients, especially in nondipper patients and patients with carotid atherosclerotic plaque, were markedly higher than those in the control group; this was accompanied by higher IFN-γ and IL-17 levels. In contrast, the Th2 frequencies and IL-4 levels in hypertensive patients, especially in nondipper patients and patients with carotid atherosclerotic plaque, were significantly lower than those in the control group. Conclusions. The changes in Th1, Th2, and Th17 activity are associated with the onset of the nondipper type and carotid atherosclerotic plaque in hypertensive patients.

4 March 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
JYJing Ye
Jing Ye
YWYuan Wang
Yuan Wang
ZWZhen Wang
Zhen Wang
LLLing Liu
Ling Liu
ZYZicong Yang
Zicong Yang
JWJun Wan
Jun Wan
Cardiovascular diseases represent a complex group of clinical syndromes caused by a variety of interacting pathological factors. They include the most extensive disease population and rank first in all-cause mortality worldwide. Accumulating evidence demonstrates that cytokines play critical roles in the presence and development of cardiovascular diseases. Interleukin-12 family members, including IL-12, IL-23, IL-27 and IL-35, are a class of cytokines that regulate a variety of biological effects; they are closely related to the progression of various cardiovascular diseases, including atherosclerosis, hypertension, aortic dissection, cardiac hypertrophy, myocardial infarction, and acute cardiac injury. This paper mainly discusses the role of IL-12 family members in cardiovascular diseases, and the molecular and cellular mechanisms potentially involved in their action in order to identify possible intervention targets for the prevention and clinical treatment of cardiovascular diseases.

1 February 2019 in Life Sciences
Verified
Journal Article
Closed access
TXTing Xiao
Ting Xiao
LZLe Zhang
Le Zhang
YHYing Huang
Ying Huang
YSYing Shi
Ying Shi
JWJing Wang
Jing Wang
HLHongtao Liu
Hongtao Liu